Ameriprise Financial Inc Stoke Therapeutics, Inc. Transaction History
Ameriprise Financial Inc
- $381 Billion
- Q3 2024
A detailed history of Ameriprise Financial Inc transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 14,315 shares of STOK stock, worth $157,751. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,315
Previous 10,305
38.91%
Holding current value
$157,751
Previous $139,000
25.9%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding STOK
# of Institutions
125Shares Held
57.6MCall Options Held
9.3KPut Options Held
35.2K-
Skorpios Trust8.91MShares$98.1 Million99.85% of portfolio
-
Black Rock Inc. New York, NY5.41MShares$59.6 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.19MShares$57.2 Million22.82% of portfolio
-
Redmile Group, LLC San Francisco, CA4.71MShares$51.9 Million3.79% of portfolio
-
Rtw Investments, LP New York, NY4.65MShares$51.3 Million0.91% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $434M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...